Vedolizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Vedolizumab and local guidelines before prescribing.

Gut-selective biologic

Mechanism

Gut-selective alpha-4 beta-7 integrin antagonist.

Uses

Ulcerative colitis, Crohn disease.

Dosing

Side effects

Infections, headache, arthralgia, infusion reactions.

Interactions

Avoid with natalizumab.

Contraindications and cautions

Active severe infection

Monitoring

Infection signs

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Slow onset; check response at 14 weeks.

More from the textbook: uses, cautions and other points
Where it is discussed in the book